10-Q quarterly report · filed Nov 5, 2026

iRhythm Holdings, Inc. (IRTC) Q3 2026 10-Q Quarterly Report

Short answer

iRhythm Holdings, Inc. (IRTC) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $222M (up 14.9% year over year) with net income of −$30M.

Q3 2026 key financials · XBRL

Revenue
$222M
+14.9% YoY · −1.2% QoQ
Net income
−$30M
−472.7% YoY · −7734.9% QoQ
Operating margin
-14.7%
Gross margin
74.2%
EPS (diluted)
−$0.91
−468.8% YoY · −9000.0% QoQ

Source: XBRL data from the iRhythm Holdings, Inc. (IRTC) Q3 2026 10-Q on SEC EDGAR. USD.

iRhythm Holdings, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $221.6M, up 15% YoY from $192.9M, driven by higher Zio monitor and Zio AT volumes
  • Gross margin 74.2% vs 71.1% YoY, supported by $3.1M tariff refunds and manufacturing efficiencies
  • Net loss $29.9M vs $5.2M, including $49.8M litigation settlements and $6.6M transformation costs
  • Cash $394.7M, marketable securities $166.0M, operating cash flow $29.3M vs $54.7M
  • VitalConnect acquisition closed October 5 for approximately $237.5M cash, with macroeconomic pressure and payer reimbursement challenges remaining headwinds

Risk Factors

  • New acquisition risk: VitalConnect acquired October 5, 2026, creating integration challenges across regulatory, quality, clinical, and billing functions
  • Most materially updated regulatory risk: FDA QMSR effective February 2, 2026, creating uncertainty around future device-quality inspections
  • Legal and compliance risk: DOJ civil investigative demand dated December 12, 2025, seeks information on Zio AT and related reimbursement claims
  • Near-term operational risk: AI-enabled payer audits increase billing scrutiny and could delay or reduce revenue and accounts receivable
  • Financial risk: Medicare represented approximately 26% of total revenue during the three and nine months ended September 30, 2026

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other iRhythm Holdings, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.